2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bicalutamide Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-9F13907
Home | Market Reports | Health| Pharmacy
Global Bicalutamide Tablets Market Research Report 2023
BUY CHAPTERS

Global Bicalutamide Tablets Market Research Report 2025

Code: QYRE-Auto-9F13907
Report
May 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bicalutamide Tablets Market

The global market for Bicalutamide Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Bicalutamide Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bicalutamide Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bicalutamide Tablets include AstraZeneca, Fosun Pharma, HISUN, FORWARD, CordenPharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bicalutamide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bicalutamide Tablets.
The Bicalutamide Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bicalutamide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bicalutamide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bicalutamide Tablets Market Report

Report Metric Details
Report Name Bicalutamide Tablets Market
Segment by Type
  • 14 Tablets Per Box
  • 28 Tablets Per Box
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Fosun Pharma, HISUN, FORWARD, CordenPharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bicalutamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bicalutamide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Bicalutamide Tablets Market report?

Ans: The main players in the Bicalutamide Tablets Market are AstraZeneca, Fosun Pharma, HISUN, FORWARD, CordenPharma

What are the Application segmentation covered in the Bicalutamide Tablets Market report?

Ans: The Applications covered in the Bicalutamide Tablets Market report are Hospital, Clinic

What are the Type segmentation covered in the Bicalutamide Tablets Market report?

Ans: The Types covered in the Bicalutamide Tablets Market report are 14 Tablets Per Box, 28 Tablets Per Box

1 Bicalutamide Tablets Market Overview
1.1 Product Definition
1.2 Bicalutamide Tablets by Type
1.2.1 Global Bicalutamide Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 14 Tablets Per Box
1.2.3 28 Tablets Per Box
1.3 Bicalutamide Tablets by Application
1.3.1 Global Bicalutamide Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Bicalutamide Tablets Market Size Estimates and Forecasts
1.4.1 Global Bicalutamide Tablets Revenue 2020-2031
1.4.2 Global Bicalutamide Tablets Sales 2020-2031
1.4.3 Global Bicalutamide Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bicalutamide Tablets Market Competition by Manufacturers
2.1 Global Bicalutamide Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bicalutamide Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bicalutamide Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bicalutamide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bicalutamide Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bicalutamide Tablets, Product Type & Application
2.7 Global Key Manufacturers of Bicalutamide Tablets, Date of Enter into This Industry
2.8 Global Bicalutamide Tablets Market Competitive Situation and Trends
2.8.1 Global Bicalutamide Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bicalutamide Tablets Players Market Share by Revenue
2.8.3 Global Bicalutamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bicalutamide Tablets Market Scenario by Region
3.1 Global Bicalutamide Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bicalutamide Tablets Sales by Region: 2020-2031
3.2.1 Global Bicalutamide Tablets Sales by Region: 2020-2025
3.2.2 Global Bicalutamide Tablets Sales by Region: 2026-2031
3.3 Global Bicalutamide Tablets Revenue by Region: 2020-2031
3.3.1 Global Bicalutamide Tablets Revenue by Region: 2020-2025
3.3.2 Global Bicalutamide Tablets Revenue by Region: 2026-2031
3.4 North America Bicalutamide Tablets Market Facts & Figures by Country
3.4.1 North America Bicalutamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bicalutamide Tablets Sales by Country (2020-2031)
3.4.3 North America Bicalutamide Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bicalutamide Tablets Market Facts & Figures by Country
3.5.1 Europe Bicalutamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bicalutamide Tablets Sales by Country (2020-2031)
3.5.3 Europe Bicalutamide Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bicalutamide Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Bicalutamide Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bicalutamide Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Bicalutamide Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bicalutamide Tablets Market Facts & Figures by Country
3.7.1 Latin America Bicalutamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bicalutamide Tablets Sales by Country (2020-2031)
3.7.3 Latin America Bicalutamide Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bicalutamide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Bicalutamide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bicalutamide Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bicalutamide Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bicalutamide Tablets Sales by Type (2020-2031)
4.1.1 Global Bicalutamide Tablets Sales by Type (2020-2025)
4.1.2 Global Bicalutamide Tablets Sales by Type (2026-2031)
4.1.3 Global Bicalutamide Tablets Sales Market Share by Type (2020-2031)
4.2 Global Bicalutamide Tablets Revenue by Type (2020-2031)
4.2.1 Global Bicalutamide Tablets Revenue by Type (2020-2025)
4.2.2 Global Bicalutamide Tablets Revenue by Type (2026-2031)
4.2.3 Global Bicalutamide Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Bicalutamide Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bicalutamide Tablets Sales by Application (2020-2031)
5.1.1 Global Bicalutamide Tablets Sales by Application (2020-2025)
5.1.2 Global Bicalutamide Tablets Sales by Application (2026-2031)
5.1.3 Global Bicalutamide Tablets Sales Market Share by Application (2020-2031)
5.2 Global Bicalutamide Tablets Revenue by Application (2020-2031)
5.2.1 Global Bicalutamide Tablets Revenue by Application (2020-2025)
5.2.2 Global Bicalutamide Tablets Revenue by Application (2026-2031)
5.2.3 Global Bicalutamide Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Bicalutamide Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Bicalutamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Bicalutamide Tablets Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Fosun Pharma
6.2.1 Fosun Pharma Company Information
6.2.2 Fosun Pharma Description and Business Overview
6.2.3 Fosun Pharma Bicalutamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fosun Pharma Bicalutamide Tablets Product Portfolio
6.2.5 Fosun Pharma Recent Developments/Updates
6.3 HISUN
6.3.1 HISUN Company Information
6.3.2 HISUN Description and Business Overview
6.3.3 HISUN Bicalutamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 HISUN Bicalutamide Tablets Product Portfolio
6.3.5 HISUN Recent Developments/Updates
6.4 FORWARD
6.4.1 FORWARD Company Information
6.4.2 FORWARD Description and Business Overview
6.4.3 FORWARD Bicalutamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 FORWARD Bicalutamide Tablets Product Portfolio
6.4.5 FORWARD Recent Developments/Updates
6.5 CordenPharma
6.5.1 CordenPharma Company Information
6.5.2 CordenPharma Description and Business Overview
6.5.3 CordenPharma Bicalutamide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CordenPharma Bicalutamide Tablets Product Portfolio
6.5.5 CordenPharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bicalutamide Tablets Industry Chain Analysis
7.2 Bicalutamide Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bicalutamide Tablets Production Mode & Process Analysis
7.4 Bicalutamide Tablets Sales and Marketing
7.4.1 Bicalutamide Tablets Sales Channels
7.4.2 Bicalutamide Tablets Distributors
7.5 Bicalutamide Tablets Customer Analysis
8 Bicalutamide Tablets Market Dynamics
8.1 Bicalutamide Tablets Industry Trends
8.2 Bicalutamide Tablets Market Drivers
8.3 Bicalutamide Tablets Market Challenges
8.4 Bicalutamide Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Bicalutamide Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bicalutamide Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bicalutamide Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bicalutamide Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Bicalutamide Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bicalutamide Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bicalutamide Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bicalutamide Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bicalutamide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bicalutamide Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bicalutamide Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Bicalutamide Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bicalutamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bicalutamide Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bicalutamide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bicalutamide Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Bicalutamide Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Bicalutamide Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Bicalutamide Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Bicalutamide Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bicalutamide Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Bicalutamide Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bicalutamide Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Bicalutamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bicalutamide Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Bicalutamide Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Bicalutamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bicalutamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bicalutamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bicalutamide Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Bicalutamide Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Bicalutamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bicalutamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bicalutamide Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bicalutamide Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Bicalutamide Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Bicalutamide Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bicalutamide Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bicalutamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bicalutamide Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Bicalutamide Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Bicalutamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bicalutamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bicalutamide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bicalutamide Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Bicalutamide Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Bicalutamide Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bicalutamide Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bicalutamide Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Bicalutamide Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Bicalutamide Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Bicalutamide Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Bicalutamide Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bicalutamide Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bicalutamide Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Bicalutamide Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Bicalutamide Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Bicalutamide Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Bicalutamide Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Bicalutamide Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Bicalutamide Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Bicalutamide Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Bicalutamide Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bicalutamide Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bicalutamide Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Bicalutamide Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Bicalutamide Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Bicalutamide Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Bicalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Bicalutamide Tablets Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Fosun Pharma Company Information
 Table 76. Fosun Pharma Description and Business Overview
 Table 77. Fosun Pharma Bicalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Fosun Pharma Bicalutamide Tablets Product
 Table 79. Fosun Pharma Recent Developments/Updates
 Table 80. HISUN Company Information
 Table 81. HISUN Description and Business Overview
 Table 82. HISUN Bicalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. HISUN Bicalutamide Tablets Product
 Table 84. HISUN Recent Developments/Updates
 Table 85. FORWARD Company Information
 Table 86. FORWARD Description and Business Overview
 Table 87. FORWARD Bicalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. FORWARD Bicalutamide Tablets Product
 Table 89. FORWARD Recent Developments/Updates
 Table 90. CordenPharma Company Information
 Table 91. CordenPharma Description and Business Overview
 Table 92. CordenPharma Bicalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CordenPharma Bicalutamide Tablets Product
 Table 94. CordenPharma Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Bicalutamide Tablets Distributors List
 Table 98. Bicalutamide Tablets Customers List
 Table 99. Bicalutamide Tablets Market Trends
 Table 100. Bicalutamide Tablets Market Drivers
 Table 101. Bicalutamide Tablets Market Challenges
 Table 102. Bicalutamide Tablets Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bicalutamide Tablets
 Figure 2. Global Bicalutamide Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bicalutamide Tablets Market Share by Type: 2024 & 2031
 Figure 4. 14 Tablets Per Box Product Picture
 Figure 5. 28 Tablets Per Box Product Picture
 Figure 6. Global Bicalutamide Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bicalutamide Tablets Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Bicalutamide Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Bicalutamide Tablets Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Bicalutamide Tablets Sales (2020-2031) & (K Units)
 Figure 13. Global Bicalutamide Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 14. Bicalutamide Tablets Report Years Considered
 Figure 15. Bicalutamide Tablets Sales Share by Manufacturers in 2024
 Figure 16. Global Bicalutamide Tablets Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Bicalutamide Tablets Players: Market Share by Revenue in Bicalutamide Tablets in 2024
 Figure 18. Bicalutamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Bicalutamide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Bicalutamide Tablets Sales Market Share by Country (2020-2031)
 Figure 21. North America Bicalutamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 22. United States Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Bicalutamide Tablets Sales Market Share by Country (2020-2031)
 Figure 25. Europe Bicalutamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Bicalutamide Tablets Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Bicalutamide Tablets Revenue Market Share by Region (2020-2031)
 Figure 33. China Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Bicalutamide Tablets Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Bicalutamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Bicalutamide Tablets Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Bicalutamide Tablets Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Bicalutamide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Bicalutamide Tablets by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Bicalutamide Tablets by Type (2020-2031)
 Figure 52. Global Bicalutamide Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Bicalutamide Tablets by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Bicalutamide Tablets by Application (2020-2031)
 Figure 55. Global Bicalutamide Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 56. Bicalutamide Tablets Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart